CZR Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Caesars Entertainment Inc (CZR) is not a strong buy at the moment for a beginner investor with a long-term focus. While there are some positive catalysts, the financial performance and technical indicators suggest caution. The stock's recent performance, lack of strong trading signals, and mixed analyst sentiment do not provide a compelling case for immediate investment.
The MACD is negatively expanding (-0.205), indicating bearish momentum. RSI is neutral at 53.611, and moving averages are converging, showing no clear trend. The stock is trading below the pivot point of 27.311, with support at 26.36 and resistance at 28.263. Overall, the technical indicators suggest a lack of strong upward momentum.
Reports of potential takeover interest, including from Tillman Fertitta, which could provide a floor for the stock price.
Las Vegas is a strong contender to host the 2029 Super Bowl, which could boost tourism and economic recovery in the region.
Diameter Capital Partners' acquisition of 850,000 shares reflects confidence in the company's growth.
Legalization of sports betting linked to increased credit card delinquency rates, which may impact consumer spending.
Introduction of legislative acts targeting prediction markets and sports betting could create regulatory uncertainty.
Weak financial performance in Q4 2025, with a significant drop in net income (-2372.73% YoY) and EPS (-2540.00% YoY).
In Q4 2025, revenue increased by 4.18% YoY to $2.916 billion. However, net income dropped significantly to -$250 million, and EPS fell to -1.22. Gross margin also declined slightly to 34.57%. The financials indicate growth in revenue but severe profitability challenges.
Analyst sentiment is mixed. Recent upgrades include Morgan Stanley raising the price target to $32 from $25, citing potential takeover interest. However, most analysts have lowered their price targets, reflecting concerns about muted recovery in Las Vegas and uneven performance in digital segments. Ratings range from Equal Weight to Buy, with price targets between $25 and $44.
